MedTrace Logo

Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences

NCT00128453 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2012-06-07

No results posted yet for this study

Summary

The purpose of the study is to determine whether colchicine is safe and effective in the treatment of acute pericarditis and the prevention of subsequent recurrences.

Conditions

  • Pericarditis

Interventions

DRUG

Colchicine (for 3 months)

Colchicine 0.5mg BID (patients\>70Kg) or 0.5mg once daily

DRUG

Placebo

placebo

Sponsors & Collaborators

  • Azienda Sanitaria Locale 3, Torino

    lead OTHER

Principal Investigators

  • Rita TRINCHERO, MD · Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy.

  • Massimo IMAZIO, MD · Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy.

  • Massimo IMAZIO, MD · Cardiology Department. Maria Vittoria Hospital, ASL 3 Torino. Italy.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00128453 on ClinicalTrials.gov